Chromosomal changes in dysplastic nevi

Cancer Genetics and Cytogenetics

Volumn 113, Issue 2, 1999, Pages 177-179

  Marras, Susanna ^a   Faa, Gavino ^a   Dettori, Tinuccia ^a   Congiu, Luciana ^a   Vanni, Roberta ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHROMOSOME ABERRATION; CYTOGENETICS; DYSPLASTIC NEVUS; FAMILY HISTORY; GENE TRANSLOCATION; HISTOLOGY; HUMAN; MELANOMA; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; HYPERPLASIA; KARYOTYPING; MELANOCYTES;

EID: 0032789706     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00019-9     Document Type: Article

References (13)

1. Parmiter A.H., Nowell P.C. Cytogenetics of melanocytic tumors. J Invest Dermatol. 100:1993;254S-258S.
2. Lever W.F., Schaumburg-Lever G. Benign melanocytic tumors and malignant melanoma. Lever W.F., Schaumburg-Lever G. Hystopathology of the Skin. ed. 7:1990;770-771 J. B. Lippincott Company, Philadelphia;
3. Clark W.H. Jr., Reimer R.R., Greene M., Ainsworth A.M., Mastrangelo M.J. Origin of familial malignant melanoma from heritable melanocytic lesions. the B-K mole syndrome Arch Dermatol. 114:1978;732-738.
4. Rabari H., Mehregan A.H. Sporadic atypical mole syndrome. Arch Dermatol. 117:1981;329-331.
5. Cowan J.M., Halaban R., Francke U. Cytogenetic analysis of melanocytes from malignant nevi and melanomas. J Natl Cancer Inst. 80:1988;1159-1164.
6. Parmiter A.H., Balaban G., Clark W.H. Jr., Nowell P.C. Possible involvement of the chromosome region 10q24→q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet. 30:1988;313-317.
7. Vanni R., Marras S., Andria M., Faa G. Endometrial polyps with predominant stromal component are characterized by a t(6;14)(p21;q24) translocation. Cancer Res. 55:1995;31-33.
8. Hastrup N., Clemmensen O.J., Spaun E., Sondergaard K. Dysplastic nevus. histological criteria and their inter-observer reproducibility Histopathology. 24:1994;503-509.
9. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
10. Richmond A., Fine R., Murray D., Lawson D.H., Priest J.H. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol. 86:1986;295-302.
11. Thompson F.H., Emerson J., Olson S., Weinstein R., Leavitt S.A., Leong S.P.L., Emerson S., Trent J.M., Nelson M.A., Salmon S.E., Tatle R. Cytogenetics of 158 patients with regional or disseminated melanoma. subset analysis of near-diploid and simple karyotypes Cancer Genet Cytogenet. 83:1995;93-104.
12. Sandberg A.A. The Chromosomes in Human Cancer and Leukemia. ed 2:1990;Elsevier, New York.
13. Kraemer K.H., Greene M.H., Elder E.D., Clark W.H. Jr., Guerry D. IV Dysplastic naevi and cutaneous melanoma risk. Lancet. 2:1983;1076-1077.